|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Impairment of privately-held investment | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (loss), net | |||||
| Interest income | |||||
| Gain on deconsolidation of the JV Company | |||||
| Loss on changes of equity interest in the JV Company, net | |||||
| Interest expenses | |||||
| Net loss before income taxes and equity method investment income (loss) | |||||
| Income tax expense (benefit) | |||||
| Net loss before equity method investment income (loss) | |||||
| Equity method investment income (loss) | |||||
| Net loss | |||||
| Equity method investment loss from equity investee | |||||
| Net income attributable to noncontrolling interest | |||||
| Net loss per common share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common share used to compute net loss per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...